Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Monoamine transporters—including the **serotonin transporter (SERT)**, **norepinephrine transporter (NET)**, and **dopamine transporter (DAT)**—are integral membrane proteins of the SLC6 family that mediate the high-affinity reuptake of their respective monoamine neurotransmitters from the synaptic cleft into the presynaptic neuron, thereby terminating neurotransmitter signaling and regulating synaptic monoamine levels[2][4][5][8]. Each transporter consists of 12 transmembrane helices and relies on sodium and chloride co-transport to drive neurotransmitter uptake against a concentration gradient[2][4][5][7][8]. Their modulation by drugs underlies the efficacy of many antidepressants, psychostimulants, and analgesics, while their dysfunction is implicated in psychiatric and neurological disorders[3][4][8].
Inhibition of neurotransmitter reuptake, increasing extracellular monoamine levels in the synaptic cleft\nCompetitive and noncompetitive inhibition\nSubstrate translocation and reverse transport (depending on the drug)\nModulation of transporter conformation
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin transporter, Norepinephrine transporter, Dopamine transporter.